(Q47791527)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

non-alcoholic fatty liver

31 January 2020

main subject

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

2

Hideyuki Hyogo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Tadashi Ikegami

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Teruo Miyazaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Katsutoshi Tokushige

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Etsuko Hashimoto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Kazuo Inui

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yasushi Matsuzaki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Susumu Tazuma

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

9 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

1257-1266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22569763%20AND%20SRC:MED&resulttype=core&format=json

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Liver fat in the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Sterol regulators of cholesterol homeostasis and beyond: the oxysterol hypothesis revisited and revised

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Ligand specificity and evolution of liver X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Approaches to measuring cholesterol absorption in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Effects of diabetes mellitus on cholesterol metabolism in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Highly sensitive analysis of sterol profiles in human serum by LC-ESI-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Highly sensitive and specific analysis of sterol profiles in biological samples by HPLC-ESI-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Highly sensitive quantification of 7alpha-hydroxy-4-cholesten-3-one in human serum by LC-ESI-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Rapid measurement of plasma acylcarnitines by liquid chromatography-tandem mass spectrometry without derivatization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Transport of side-chain oxidized oxysterols in the human circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Cholesterol 25-hydroxylation activity of CYP3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Serum concentration of 27-hydroxycholesterol predicts the effects of high-cholesterol diet on plasma LDL cholesterol level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Hepatic insulin resistance directly promotes formation of cholesterol gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Bile acids as regulators of hepatic lipid and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0585-0

Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity

21 January 2018

1 reference

12 December 2020

Cholesterol absorption efficiency and sterol metabolism in obesity

1 reference

12 December 2020

Cholesterol production in obesity

1 reference

12 December 2020

Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption

1 reference

12 December 2020

Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population

1 reference

12 December 2020

Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis

1 reference

12 December 2020

Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease.

1 reference

12 December 2020

Highly sensitive quantification of serum malonate, a possible marker for de novo lipogenesis, by LC-ESI-MS/MS.

1 reference

12 December 2020

A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients

1 reference

12 December 2020

Cholesterol synthesis prevails over absorption in metabolic syndrome

1 reference

12 December 2020

Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry

1 reference

12 December 2020

Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients

1 reference

12 December 2020

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

1 reference

12 December 2020